Cardinal Health Inc
Latest Cardinal Health Inc News and Updates
Is Cardinal Health Stock a Buy or Sell at the Current Prices?
Investment-Grade Bond Funds Saw Outflows Last Week
Flows into investment-grade bond funds (LQD) were negative in the week ending June 17. This was the second consecutive week witnessing outflows.
Issuance of Investment-Grade Corporate Bonds Fell Last Week
Baxalta, Energy Transfer Partners, JPMorgan Chase, Occidental Petroleum, and Cardinal Health were among the biggest issuers of investment-grade corporate bonds last week.
Analyzing Gilead Sciences’ Research Pipeline Developments
On October 3, Gilead Sciences (GILD) reported the results from a phase three study evaluating Biktarvy’s safety and efficacy.
How GlaxoSmithKline Stock Has Performed in September
Analyst estimates suggest GlaxoSmithKline stock could rise ~6.3% over the next 12 months.
Pfizer’s Earnings Quality and Dividend Performance
Pfizer’s dividend yield is 3.09%. Its dividend yield last year was 3.53%, and its five-year average yield is 3.44%.
How Pharmacies and Drugstores Are Defending against Amazon
Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.
Behind Depomed’s Business Strategy
Depomed (DEPO) has adopted a three-pronged business strategy with three key elements: maintain, build, and grow.
Analysts’ Ratings for AmerisourceBergen in March 2018
Four analysts gave AmerisourceBergen stock a “strong buy” rating, seven analysts gave it a “buy” rating, and seven analysts gave it a “hold” rating.
Analyzing AmerisourceBergen’s Recent Acquisitions
In December 2017, AmerisourceBergen (ABC) acquired Northeast Supply Company, or NEVSCO, for a consideration of $70 million.
Discussing Baxter International’s Recent Stock Price Highs
On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share.
Patient Recovery Acquisition May Boost Cardinal Health’s Revenues
On July 30, 2017, Cardinal Health (CAH) completed the acquisition of Medtronic’s patient recovery business for an all-cash consideration worth $6.1 billion.
Robust Growth Expected for Cardinal Health’s Specialty Solutions
Cardinal Health’s (CAH) Specialty Solutions segment provides two types of services: upstream to pharmaceutical and biopharmaceutical manufacturers and downstream to healthcare providers.
Cardinal Health: Stable Net Profit Margins in Fiscal 2018?
Wall Street analysts have projected Cardinal Health’s fiscal 2018 net profit margins to be 1.0%, which will be similar to what the company reported in fiscal 2017.
Cardinal Health Expected to Report Modest Revenue Growth
For fiscal 2018, Cardinal Health (CAH) has projected mid-single-digit revenue growth on a YoY basis, partially driven by the company’s high customer retention rates.
Divestiture of a Part of Medtronic’s PMR Business to Cardinal Health
Medtronics’ MITG (Minimally Invasive Therapies Group) business is expected to grow 3.5%–4.5%.
Dividend Yield of Cardinal Health
Cardinal Health’s (CAH) PE ratio of 16.0x compares to a sector average of 20.4x. The dividend yield of 2.9% compares to a sector average of 2.0%.
Medtronic Will Divest Part of Its PMR Business to Cardinal Health
On April 18, Medtronic announced the divestiture of its Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses to Cardinal Health.
An Above-Average One-Year Period for Vanguard Morgan Growth Fund
The Vanguard Morgan Growth Fund – Investor Shares (VMRGX) is invested in stocks of companies like Nike (NKE), Netflix (NFLX), The Walt Disney Company (DIS), Cardinal Health (CAH), and Vantiv (VNTV).
How Have XLV’s Large-Caps Performed?
XLV has 49 large-cap stocks in its holdings, with a combined market cap of more than $10 billion. Among them, 47 stocks fell on March 15, 2016.
A Look at Walgreens Boots’ Pharmaceutical Wholesale Division
Walgreens Boots Alliance’s (WBA) Pharmaceutical Wholesale division consists of the legacy Alliance Boots pharmaceutical wholesaling and distribution businesses.
Walgreens Boots Alliance: Merger of Walgreens and Alliance Boots
Walgreens became a wholly owned subsidiary of Walgreens Boots Alliance after a merger.
Henry Schein Acquired RxWorks and Greggs Increased Sales
Henry Schein reported 3Q15 net sales of $2,685.8 million, a rise of 2.4% compared to the net sales of $2,623.7 million in fiscal 3Q14.
Analyzing Cost Structure for Medical Device Companies
As per the US Census, spending on medical devices in the US has been constant for over a decade between 2005 to 2015.
Assessing Medtronic’s Marketing and Sales Strategy in 2015
To extend cost-effective, high-quality medical devices and therapies, Medtronic aims to organize its marketing and sales teams around physician preferences.
China’s November 2015 PMI Pressured Oil Prices, US Market Bullish
US investors seemed to take the weak Chinese manufacturing data released by Caixin in stride on November 2. China’s PMI rose from September’s reading of 47.2 to 48.3 for October 2015.
Drivers That Impact CVS’s Pharmacy Services Segment
CVS Health (CVS) is projecting 2Q15 revenue growth between 11.25% and 12.5% for its Pharmacy Services, which provides pharmacy benefit management (or PBM) services.
How CVS Plans to Make Target’s Pharmacies Profitable
CVS is planning to transfer Target’s generic business to Red Oak Sourcing. Target currently sources from McKesson.
Does Johnson & Johnson Have a Plan for Huge Cash Reserve?
Johnson & Johnson (JNJ) has a huge cash reserve amounting to ~$15 billion in 4Q14. The company might use the cash for merger and acquisition (or M&A).